ConcertoCare is a tech-enabled, value-based provider delivering comprehensive at-home care for seniors and other adults with unmet health and social needs. It deploys interdisciplinary physician-led teams — physicians, nurses, pharmacists, health coaches, behavioralists, and social workers — available in person and virtually and supported by its proprietary population health platform, Patient3D®. The company integrates medical, behavioral, and social determinants of health and uses connected devices and clinical decision support to manage complex chronic conditions and optimize care delivery. ConcertoCare works with a variety of payers, including Medicare Advantage, Medicare‑Medicaid plans, and CMS value-based programs, and can partner with a patient’s current primary care physician or serve as provider of record; it also offers PACE for qualifying members. The company serves seniors in eight states and plans to use new funding to scale delivery of its comprehensive in-home care model to more seniors; it has acquired Crown Health to accelerate growth in the Pacific Northwest. Financially, ConcertoCare has raised $149.5 million in equity to date, including a $105 million Series B announced Feb. 3, 2022. ConcertoHealth delivers individualized primary and preventive care for complex, frail, elderly and dual-eligible patients across settings including care centers, homes, hospitals and outpatient facilities. Its Care Model bundles hospital-based physicians, nurse case managers, care coordinators, social workers, pharmacists, dieticians and logistical supports to manage high-acuity patients. The company uses proprietary population health management technology to give physicians tools to accept accountability for patient outcomes. Led by president and CEO Alec Cunningham, ConcertoHealth integrates clinical care with social services to address both medical and non-medical needs. The company intends to use recent funding to expand its care model with new and existing payor partners. No operating metrics were disclosed in the article.

Total raised

$135M

Funding rounds

2

Latest round

Series B

Latest activity

Feb 2022